434 related articles for article (PubMed ID: 28130986)
1. Recognition of substrate degrons by E3 ubiquitin ligases and modulation by small-molecule mimicry strategies.
Lucas X; Ciulli A
Curr Opin Struct Biol; 2017 Jun; 44():101-110. PubMed ID: 28130986
[TBL] [Abstract][Full Text] [Related]
2. Homo-PROTACs: bivalent small-molecule dimerizers of the VHL E3 ubiquitin ligase to induce self-degradation.
Maniaci C; Hughes SJ; Testa A; Chen W; Lamont DJ; Rocha S; Alessi DR; Romeo R; Ciulli A
Nat Commun; 2017 Oct; 8(1):830. PubMed ID: 29018234
[TBL] [Abstract][Full Text] [Related]
3. Systematic prediction of degrons and E3 ubiquitin ligase binding via deep learning.
Hou C; Li Y; Wang M; Wu H; Li T
BMC Biol; 2022 Jul; 20(1):162. PubMed ID: 35836176
[TBL] [Abstract][Full Text] [Related]
4. Design Principles Involving Protein Disorder Facilitate Specific Substrate Selection and Degradation by the Ubiquitin-Proteasome System.
Guharoy M; Bhowmick P; Tompa P
J Biol Chem; 2016 Mar; 291(13):6723-31. PubMed ID: 26851277
[TBL] [Abstract][Full Text] [Related]
5. How the ends signal the end: Regulation by E3 ubiquitin ligases recognizing protein termini.
Sherpa D; Chrustowicz J; Schulman BA
Mol Cell; 2022 Apr; 82(8):1424-1438. PubMed ID: 35247307
[TBL] [Abstract][Full Text] [Related]
6. Prospective discovery of small molecule enhancers of an E3 ligase-substrate interaction.
Simonetta KR; Taygerly J; Boyle K; Basham SE; Padovani C; Lou Y; Cummins TJ; Yung SL; von Soly SK; Kayser F; Kuriyan J; Rape M; Cardozo M; Gallop MA; Bence NF; Barsanti PA; Saha A
Nat Commun; 2019 Mar; 10(1):1402. PubMed ID: 30926793
[TBL] [Abstract][Full Text] [Related]
7. Development of targeted protein degradation therapeutics.
Chamberlain PP; Hamann LG
Nat Chem Biol; 2019 Oct; 15(10):937-944. PubMed ID: 31527835
[TBL] [Abstract][Full Text] [Related]
8. Perspectives on the development of first-in-class protein degraders.
Rambacher KM; Calabrese MF; Yamaguchi M
Future Med Chem; 2021 Jul; 13(14):1203-1226. PubMed ID: 34015962
[TBL] [Abstract][Full Text] [Related]
9. The Eukaryotic Proteome Is Shaped by E3Â Ubiquitin Ligases Targeting C-Terminal Degrons.
Koren I; Timms RT; Kula T; Xu Q; Li MZ; Elledge SJ
Cell; 2018 Jun; 173(7):1622-1635.e14. PubMed ID: 29779948
[TBL] [Abstract][Full Text] [Related]
10. Lessons in PROTAC Design from Selective Degradation with a Promiscuous Warhead.
Bondeson DP; Smith BE; Burslem GM; Buhimschi AD; Hines J; Jaime-Figueroa S; Wang J; Hamman BD; Ishchenko A; Crews CM
Cell Chem Biol; 2018 Jan; 25(1):78-87.e5. PubMed ID: 29129718
[TBL] [Abstract][Full Text] [Related]
11. Multifaceted N-Degron Recognition and Ubiquitylation by GID/CTLH E3 Ligases.
Chrustowicz J; Sherpa D; Teyra J; Loke MS; Popowicz GM; Basquin J; Sattler M; Prabu JR; Sidhu SS; Schulman BA
J Mol Biol; 2022 Jan; 434(2):167347. PubMed ID: 34767800
[TBL] [Abstract][Full Text] [Related]
12. Targeted protein degradation and the enzymology of degraders.
Fisher SL; Phillips AJ
Curr Opin Chem Biol; 2018 Jun; 44():47-55. PubMed ID: 29885948
[TBL] [Abstract][Full Text] [Related]
13. Protein quality control degron-containing substrates are differentially targeted in the cytoplasm and nucleus by ubiquitin ligases.
Hickey CM; Breckel C; Zhang M; Theune WC; Hochstrasser M
Genetics; 2021 Mar; 217(1):1-19. PubMed ID: 33683364
[TBL] [Abstract][Full Text] [Related]
14. The role of reversible and irreversible covalent chemistry in targeted protein degradation.
Kiely-Collins H; Winter GE; Bernardes GJL
Cell Chem Biol; 2021 Jul; 28(7):952-968. PubMed ID: 33789091
[TBL] [Abstract][Full Text] [Related]
15. DegronMD: Leveraging Evolutionary and Structural Features for Deciphering Protein-Targeted Degradation, Mutations, and Drug Response to Degrons.
Xu H; Hu R; Zhao Z
Mol Biol Evol; 2023 Dec; 40(12):. PubMed ID: 37992195
[TBL] [Abstract][Full Text] [Related]
16. Expanding the ligand spaces for E3 ligases for the design of protein degraders.
Shah Zaib Saleem R; Schwalm MP; Knapp S
Bioorg Med Chem; 2024 May; 105():117718. PubMed ID: 38621319
[TBL] [Abstract][Full Text] [Related]
17. C-terminal glutamine acts as a C-degron targeted by E3 ubiquitin ligase TRIM7.
Ru Y; Yan X; Zhang B; Song L; Feng Q; Ye C; Zhou Z; Yang Z; Li Y; Zhang Z; Li Q; Mi W; Dong C
Proc Natl Acad Sci U S A; 2022 Jul; 119(30):e2203218119. PubMed ID: 35867826
[TBL] [Abstract][Full Text] [Related]
18. Differential PROTAC substrate specificity dictated by orientation of recruited E3 ligase.
Smith BE; Wang SL; Jaime-Figueroa S; Harbin A; Wang J; Hamman BD; Crews CM
Nat Commun; 2019 Jan; 10(1):131. PubMed ID: 30631068
[TBL] [Abstract][Full Text] [Related]
19. Building yeast libraries to dissect terminal degrons with fluorescent timers.
Kong KE; Reinbold C; Knop M; Khmelinskii A
Methods Enzymol; 2023; 686():297-319. PubMed ID: 37532405
[TBL] [Abstract][Full Text] [Related]
20. Small-molecule PROTACs: novel agents for cancer therapy.
Wan Y; Yan C; Gao H; Liu T
Future Med Chem; 2020 May; 12(10):915-938. PubMed ID: 32270707
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
